[1]毛彦娜,田　亮,刘　炜,等.不同抗真菌药物治疗儿童侵袭性肺曲霉病疗效比较[J].新乡医学院学报,2016,33(9):774-776.[doi:10.7683/xxyxyxb.2016.09.009]
　MAO Yan-na,TIAN Liang,LIU Wei,et al.Comparison of the effect of different antifungal medicines in treatment of children with invasive pulmonary aspergillosis[J].Journal of Xinxiang Medical University,2016,33(9):774-776.[doi:10.7683/xxyxyxb.2016.09.009]
点击复制

不同抗真菌药物治疗儿童侵袭性肺曲霉病疗效比较
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
33
期数:
2016年9
页码:
774-776
栏目:
临床研究
出版日期:
2016-08-23

文章信息/Info

Title:
Comparison of the effect of different antifungal medicines in treatment of children with invasive pulmonary aspergillosis
作者:
毛彦娜1; 田　亮1; 刘　炜1; 李彦格1; 刘俊闪2; 宋丽丽1; 包丰昌1; 周建文1; 张红梅1
（1.郑州市儿童医院血液肿瘤科，河南　郑州　450053；2.郑州市儿童医院血液肿瘤科实验室,河南　郑州　450053）
Author(s):
MAO Yan-na1; TIAN Liang1; LIU Wei1; LI Yan-ge1; LIU Jun-shan2; SONG Li-li1; BAO Feng-chang1; ZHOU Jian-wen1; ZHANG Hong-mei1
(1.Department of Hematology and Oncology,Zhengzhou Children′s Hospital,Zhengzhou 450053，Henan Province，China；2.Hematology and Oncology Laboratory，Zhengzhou Children′s Hospital,Zhengzhou 450053，Henan Province，China)
关键词:
儿童; 侵袭性曲霉菌病; 临床特点; 伏立康唑
Keywords:
child; invasive pulmonary aspergillosis; clinical features; voriconazole
分类号:
R725.6
DOI:
10.7683/xxyxyxb.2016.09.009
文献标志码:
A
摘要:
目的　探讨不同抗真菌药物治疗侵袭性肺曲霉病(IPA)的疗效及安全性。方法　收集2008年1月至2013年7月郑州市儿童医院血液肿瘤科IPA患儿96例，根据应用抗真菌药物种类的不同分为伏立康唑组40例、两性霉素B组30例和卡泊芬净组26例。回顾性分析96例患儿影像学及病原学检查结果，并比较3组患儿临床疗效和不良反应。结果　96例IPA患儿中，胸部影像学表现为节段性肺实变45例（46.9%），多发或单发结节阴影38例（39.6%）；血清半乳糖（GM）连续2次阳性72例(75.0%）。与卡泊芬净组（69.2％，18/26）比较，伏立康唑组（95.0％，38/40）与两性霉素B组（86.7％，26/30）治疗有效率显著升高(P<0.05)；伏立康唑组治疗有效率虽然高于两性霉素B组，但其差异无统计学意义(P>0.05)。与两性霉素B组比较，伏立康唑组、卡泊芬净组患者高热、寒战、低钾血症、肝功能异常等不良反应发生率显著降低(P<0.01)；伏立康唑组患儿平均退热时间［（1.5±1.0）d］显著短于卡泊芬净组［（7.0±1.5）d］（P<0.05）。结论　伏立康唑治疗IPA患儿疗效显著，安全性高，且退热快。
Abstract:
Objective　To investigate the efficacy and safety of different antifungal medicines in treatment of children with invasive pulmonary aspergillosis (IPA).Methods　A total of 96 children with IPA in Department of Hematonosis and Oncosis，Zhengzhou Children′s Hospital from January 2008 to July 2013 were selected and divided into voriconazole group (n=40),amphotericin B group (n=30) and caspofungin group (n=26) according to the types of antifungal medicines used.The imageology and aetiology result of the 96 cases were analyzed retrospectively，and the clinical effect and adverse effect were compared among the three groups.Results　Of the 96 cases of IPA patients，there were 45 cases（46.9%）of segmental pulmonary consolidation，38 cases（39.6%）of multiple or single nodule shadows in the chest imaging；72 cases（75.0%） had twice consecutive positive of serum glactomannan(GM).The effective rate of voriconazole（95.0％,38/40） and amphotericin B group（86.7％,26/30） was significantly higher than that of caspofungin group（69.2％,18/26） (P<0.05).Also the voriconazole group overtops amphotericin B group in effective rates,but the difference had no statistically significance (P>0.05).Comparing to amphotericin B group,the incidence of hyperpyrexia,shiver,hypokalemia and hepatic dysfunction were significantly lower in voriconazole and caspofungin groups (P<0.01).The defervescence time of voriconazole group［（1.5±1.0）d］ was significantly shorter than that of caspofungin group ［（7.0±1.5）d］(P<0.05).Conclusion　Voriconazole can be used to treat IPA with remarkable curative effect and high safety and the defervescence time needed is rather short.

参考文献/References:

［1］　中华医学会儿科学分会呼吸组，《中华儿科杂志》编辑委员会.儿童侵袭性肺部真菌感染诊治指南（2009版）［J］.中华儿科杂志，2009,47（6）:96-98.
［2］　张之南,沈悌.血液病的诊断与疗效标准［M］.3版.北京:科学出版社,2007：152-163.
［3］　张之南,郝玉书，赵永强，等.血液病学［M］.2版.北京：人民卫生出版社,2011：313-316.
［4］　VALERIOR A,FABIANO N,HUANDER F A,et al.The performance of real-time PCR,galactomannan,and fungal culture in the diagnosis of invasive aspergillosis in ventilated patients with chronic obstructive pulmonary disease (COPD)［J］.Mycopathologia,2012,174(2):163-169.
［5］　中华人民共和国卫生部.抗菌药物临床应用指导原则［M］.北京：人民卫生出版社，2007:150.
［6］　KONTOYIANNIS D P,BODEY G P.Invasive aspergillosis in 2002:an update［J］.Eur J Clin Microbiol Infect Dis，2002,21（11）:161-172.
［7］　林丽敏,马廉.恶性血液病并侵入性真菌感染的诊治对策［J］.实用儿科临床杂志，2009,24（15）:1133-1136.
［8］　SUNG L,APLENC R,ALONZO T A,et al.Effectiveness of supportive care measures to reduce infections in pediatric AML:a report from the Children′s Oncology Group［J］.Blood,2013,121(20):3573-3577.
［9］　赖永洪,吴梓梁.小儿白血病的感染及抗感染治疗［J］.实用儿科临床杂志，2012,27（3）:156-159.
［10］　王锐，李伟.真菌性肺炎的临床病理及影像学分析研究［J］.中国临床医学影像杂志，2002,13（4）:249-252.
［11］　CAILLOT D,COUAILLIER J F,BERNARD A,et al.Increasing volume and changing characteristics of invasive pulmonary aspergillosin on sequential thoracic computed tomography scans in patients with neutropenia［J］.J Clin Oncol,2001,19(1):253-259.
［12］　GREENE R.The radiological spectrum of pulmonary aspergillosis［J］.Med Mycol,2005,43 (1):147-154.
［13］　HORGER M,HEBART H,EINSELE H,et al.Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients:association with patient outcome［J］.Eur J Radiol,2005,78(932):437-444.
［14］　MILITO M A,KONTOYIANNIS D P,LEWIS R E,et al.Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis［J］.Med Mycol,2010,48(12):817-823.
［15］　MARTIN T,SHARMA M,DAMON L,et al.Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation［J］.Transplant Inf Dis,2010,12(1):45-50.
［16］　CHAI L Y,KULLBERY B J,JOHNSON E M,et al.Early serum galactomanman trend as apredictor of outcom of invasive aspergillosis［J］.Clin Microbiol，2012，50(7):2330-2336.
［17］　SOUBANI A O,CHANDRASEKAR P H.The clinical spectrum of pulmonary aspergillosis［J］.Chest,2002,121(6):1988-1999.
［18］　KARAGEORGOPOULOS D E,VOULOUMANOU E K,NTZIORA F,et al.Beta-D-Glucanassay for the diagnosis of invasive fungal infections:a meta-analysis［J］.Clin Infect Dis,2011,52(6):750-770.
［19］　MARON G M,HAYDEN R T,Rodriguez A,et al.Voriconazole prophylaxis in children with cancer:changing outcomes and epidemiology of fungal infections［J］.Pediatrinfec Dis J,2013,32(12):e451-e455.
［20］　张芙蓉.伏立康唑针治疗重症监护病房儿童肺部真菌的疗效［J］.实用儿科临床杂志，2010,25（4）:262-263.
［21］　IMATAKI O,OHNISH H,KITANAKA A,et al.Visual disturbance comorbid with hallucination caused by voriconazole in the Japanese population［J］.Int J Hematol,2008,88(1):3-6.

相似文献/References:

[1]元帅,史世峰,孙丽君,等.儿童行为问题研究现状[J].新乡医学院学报,,():000.
[2]于贵珍,郑素华,张文林,等.1120例儿童及青少年行为问题的调查研究[J].新乡医学院学报,1990,7(03):201.
[3]田明德.儿童转换型癔症25例报告[J].新乡医学院学报,1990,7(03):221.
[4]张华荣,卢振民,冯连铭,等.儿童急性中耳炎鼓膜穿孔的探讨[J].新乡医学院学报,1993,10(01):033.
[5]石太新,赵卫星,王礼周,等.小儿再生障碍性贫血骨髓细胞核仁形成区蛋白定量研究[J].新乡医学院学报,1995,12(02):147.
[6]席鸿钧,陈莹,李汉臣,等.经胃壁潜道食管胃粘膜腔内吻合治疗小儿食管狭窄[J].新乡医学院学报,1995,12(03):230.
[7]薛克修,陈金兰,支凌翔,等.儿童前臂缺血性挛缩的治疗[J].新乡医学院学报,1996,13(04):384.
[8]殷琪.儿童特发性高钙尿症12例[J].新乡医学院学报,1996,13(01):091.
[9]郑素华,付桂玲,张文林,等.行为异常儿童社交能力分析[J].新乡医学院学报,1997,14(04):363.
[10]贾东萱,石太新,贾汝贤,等.小儿恶性肿瘤及白血病226例回顾性分析[J].新乡医学院学报,1997,14(04):405.

更新日期/Last Update: 2016-09-05